• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

Introduction to Carbonic Acid Sodium Salt (1:2), Hydrate (1:?) and Its Applications in Modern Science

The compound with the CAS number 24551-51-7, identified as Carbonic Acid Sodium Salt (1:2), Hydrate (1:?), represents a fascinating intersection of inorganic chemistry and pharmaceutical science. This hydrated salt, featuring a 1:2 molar ratio of sodium to carbonic acid units, has garnered significant attention in recent years due to its versatile applications and unique chemical properties. This introduction delves into the compound's structure, synthesis, and emerging roles in contemporary research, emphasizing its relevance in drug development and material science.

At its core, Carbonic Acid Sodium Salt (1:2), Hydrate (1:?) is a sodium bicarbonate derivative, characterized by its ability to exist in multiple hydrated forms. The notation "(1:2)" indicates the stoichiometric ratio between sodium ions and bicarbonate units, while "(1:?)" suggests variable hydration levels that can influence its physical and chemical behavior. This variability makes it a subject of interest for researchers seeking to optimize material properties for specific applications.

The synthesis of this compound typically involves the reaction of sodium hydroxide with carbon dioxide in an aqueous medium, followed by controlled hydration processes. The precise control of reaction conditions—such as temperature, pressure, and pH—is crucial to achieving the desired stoichiometry and hydration state. Recent advancements in sol-gel techniques have further refined the synthesis process, enabling the production of highly pure and crystalline forms of the salt. These advancements are particularly valuable for pharmaceutical applications, where purity and crystallinity are critical factors.

In pharmaceutical research, Carbonic Acid Sodium Salt (1:2), Hydrate (1:?) has been explored as a potential buffering agent due to its stability across a wide pH range. Buffering agents are essential in maintaining the pH balance of biological systems, making them indispensable in drug formulations and medical treatments. Studies have demonstrated its efficacy in stabilizing protein formulations and enhancing drug solubility, which could lead to more effective oral and injectable medications. Furthermore, its role as an excipient in controlled-release formulations has been investigated, offering promising avenues for sustained drug delivery systems.

Beyond pharmaceuticals, this compound has found utility in material science. Its ability to act as a nucleating agent in polymer matrices has been leveraged to improve the mechanical strength and thermal stability of various polymers. Researchers have reported significant enhancements in the performance of polyethylene and polypropylene composites when treated with Carbonic Acid Sodium Salt (1:2), Hydrate (1:?). Additionally, its hygroscopic nature makes it a candidate for humidity-regulating materials in packaging applications, helping to preserve sensitive goods by maintaining optimal moisture levels.

Recent studies have also highlighted the compound's potential in environmental applications. Its capacity to neutralize acidic emissions has been explored as a component in scrubber systems designed for industrial waste treatment. By converting acidic gases into harmless salts through chemical reactions, this compound contributes to reducing environmental pollution without generating hazardous byproducts. Such applications align with global efforts to develop sustainable industrial practices that minimize ecological impact.

The versatility of Carbonic Acid Sodium Salt (1:2), Hydrate (1:?) is further underscored by its use in analytical chemistry. Its well-defined crystalline structure makes it an excellent reference standard for X-ray diffraction studies, aiding researchers in characterizing unknown materials. Moreover, its thermal stability allows for precise temperature calibration in laboratory instruments, ensuring accurate measurements across various scientific disciplines.

In conclusion, Carbonic Acid Sodium Salt (1:2), Hydrate (1:?) is a multifaceted compound with broad applications spanning pharmaceuticals, material science, environmental technology, and analytical chemistry. Its unique properties—stemming from its stoichiometric composition and hydration state—make it a valuable asset for researchers seeking innovative solutions across multiple fields. As scientific understanding continues to evolve, the potential uses of this compound are likely to expand even further, reinforcing its importance as a cornerstone of modern chemical research.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)